Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202
Download the PDF here.
This post appeared first on investingnews.com
You May Also Like
World News
King Charles III used a significant speech in Canada’s parliament on Tuesday to underscore the country’s sovereignty following pressure from US President Donald Trump....
World News
Germany and other Ukrainian allies have lifted restrictions on Kyiv firing long-range missiles into Russia for the first time, the German chancellor said Monday,...
Business News
Nvidia shares jumped on Thursday after posting a positive set of earnings, sparking a rally in global semiconductor stocks. Shares of Nvidia were 6%...
Business News
Dick’s Sporting Goods said Wednesday it’s standing by its full-year guidance, which includes the expected impact from all tariffs currently in effect. The sporting...